Osteal Therapeutics Stock

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.

Sign up today and learn more about Osteal Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Osteal Therapeutics Stock

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection.

Funding History

April 2018$7.8M
November 2020$2.0M
March 2022$30.0M
September 2023$23.0M

Management

Chief Executive Officer

David Thompson

Founder, Chief Medical Officer

Brian de Beaubien

Board Member

Martin Sands

Board Member

Robert Luo

Board Member

Judson A. Cooper

Board Member

Steven Sands

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo